Amlitelimab is an investigational anti-OX40 ligand monoclonal antibody designed to normalize the overactive immune response in patients with atopic dermatitis.

New research on acetaminophen use during pregnancy; the chikungunya vaccine Ixchiq is withdrawn; FDA approves Nexplanon for up to 5 years of use; suicidal ideation warning removed from GLP-1s; at-home ...

PFS significantly higher with nivolumab, doxorubicin, vinblastine, and dacarbazine versus brentuximab vedotin-AVD.

Omalizumab or dupilumab suggested for adults with moderate-to-severe allergic asthma, history of exacerbations requiring oral ...

HealthDay News — Some canned tuna associated with a 2025 recall has been pulled from grocery stores in 9 states, federal ...

More than 80% of patients with clinically meaningful benefit at 12 months maintain that benefit at 18 and 24 months.

Significantly longer progression-free survival seen among patients with previously untreated, PD-L1 advanced or metastatic ...

No evidence of association for CWF with birth weight or other birth outcomes in study of >11 million singleton births.

Phase 3 trial results show levacetylleucine improves SARA scores in patients with the rare disorder ataxia-telangiectasia.

The investigational cortisol modulator relacorilant plus nab-paclitaxel improved survival in platinum-resistant ovarian ...

Beneficiaries with cognitive impairment and those with dementia were more likely to receive these prescriptions than those with normal cognition.

South Carolina has reported 646 cases, with numbers rising quickly; most infections involve unvaccinated people.